Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan’s Shionogi, AstraZeneca Sue Seven Generics For Violating Crestor Patent (Japan)

This article was originally published in PharmAsia News

Executive Summary

Japan's Shionogi joined with AstraZeneca in suing seven makers of generic drugs for applying in the United States for a version of Crestor (rosuvastatin calcium) for lowering cholesterol. Shionogi, the developer, said its U.S. patent for the drug is still in effect and the application violates it. AstraZeneca markets the drug. Defendants in the suit are Apotex, Aurobindo Pharma, Cobalt Pharmaceuticals, Mylan Pharmaceuticals, Pan Pharmaceuticals, Sandoz and Sun Pharmaceuticals. (Click here for more - may require a subscription



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts